Archiwum hase³
ligand-inducible transcription factors | dose rate | inverse dose rate {IDRE} | chromatin lipids | glioblastoma multiforme {GBM} | D-glucaric acid | saccharic acid | D-glucaro-1,4-lactone | sarcolemma | fatty acid translocase | fatty-acid binding protein | heart fatty acid binding protein, H-FABP | fatty-acid transport proteins | recommended daily allowance {RDA} | neural tube defects {NTDs} | buttock | bone morphogenetic proteins {BMP} | leukocyte function associated antigen 1 {LFA1} | mevalonate {MVA} | very late antigen {VLA} | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | mevalonate pathway | geranylgeranyl pyrophosphate | dolichol phosphate | pharnesyl pyrophosphate | geranyl pyrophosphate | cytophosphane | vinorelbine | flow cytometry | myelodysplastic syndromes {MDS} | progressive bone marrow failure | Pontiac fever | insulin glargine | conjoined twins | Siamese twins | locked in syndrome | genetic sexual attraction {GSA} | frontotemporal dementia (FTD) | glial scar | glycosylphosphatidylinositol {GPI} | zinc endopeptidases | biotyping | antibiogram | protein electrophoresis | cell protein profiles | bacteriophage typing | zymotyping | interferon-alpha | interferon-induced thyroid disorder | destructive thyroiditis | non-autoimmune hypothyroidism | biphasic course | fluoroquinolones | glioma | multilocus enzyme electrophoresis {MLEE} | pigment epithelium-derived factor {PEDF} | ribavirin | serotyping | osseointegration | temporal association | micronucleus | CHIP protein | selective protein degradation | chaperone | protein quality-control system | molecular mimicry | guided bone regeneration | intraosseus defects | van Gieson method | van Gieson stain | osteogenic process | cortical thinning | thinning | aerosolization | bolus injection | tendinopathy | imaging cassette | cannabinoid receptor agonists | self-administration | self-stimulation | euthyreosis | guided bone regeneration (GBR) | intercellular adhesion molecule {ICAM} | gastrointestinal stromal tumors {GIST} | cyclophosphamide | neuropilin | bioresorbable | dismetabolic syndrome | morphometric methods | molecular classification | neoplastic disease | transcriptomics | metabolomics | metabolome | investigational drug | polyamine synthesis | hepatic arginase | extrahepatic arginase | ferric reductases | substrate specificity | everolimus | zotarolimus | in-stent thrombosis | cardiogenic shock | vanilloids | resiniferatoxin | prion diseases | incubation period | physiological prion protein | pathological prion protein | disintegrin | thrombospondin | sialoprotein | dentin matrix protein1 {DMP1} | heparin-binding epidermal growth factor {HB-EGF} | hereditary leiomyomatosis and renal cell carcinoma {HLRCC } | latency associated peptide {LAP} | large latent complex {LLC} | lysyl oxidase {LOX} | protein-lysine 6-oxidase | latent TGF-β-binding protein {LTBP} | mammalian tolloid {mTLD} | mammalian tolloid-like {mTLL} | procollagen C-proteinase {PCP} | small integrin-binding ligand, N-linked glycoprotein {SIBLING} | small-leucine rich proteoglycans {SLRPs} | subtilisin | serine endopeptidase | subtilin | subtilin-like pro protein convertase {SPC} | monoclonal benign tumor | procollagen C-endopeptidase | carboxyl propeptide | prolamin | extranuclear matrix | bone sialoprotein | etoposide | cytochrome P450 isoform | ubiquitin proteasome system {UPS} | epidermal growth factor receptor {EGFR} | reactive nitrogen species {RNS} | aryl hydrocarbon receptor {Ahr}, {AHR} | persistent organic pollutants {POPs} | allyl isothiocyanate {AITC} | diode-array detector {DAD} | diindolylmethane {DIM} | estrogen response element {ERE} | indole-3-carbinol {I3C} | glucobrassicin | isothiocyanates {ITC} | near infrared spectroscopy {NIRS} | 16α-hydroxyestrone {16αOHE} | hydroxyestrone | phosphoinositide-3 kinase {PI3K} | trolox equivalents {TE} | trolox | thioredoxin reductase {TrxR} | quinone reductase {QR} | xenobiotic response element {XRE} | myrosinase | thioglucoside glucohydrolase | antioxidant response element {ARE} | non-enzymatic antioxidants | apoptosis | actin binding proteins {ABP} | actin related protein 2/ 3 {ARP2/ 3} | adenosine 5`-triphosphate {ATP} | adenosine 5`-triphosphatase {ATPaza} | ezrin | cytovillin | moesin | guanosine-5`diphosphate {GDP} | guanosine-5`triphosphatase {GTP-aza} | LIM protein {LIM} | muscle LIM protein | LIM kinase {LIMK} | microtubule associated proteins {MAPs} | mitochondrial Rho {Miro} | myosin light chains {MLC} | myosin light chains phosphatase {MLCP} | Rho proteins | molecular switches | nicastrin {NCT} | oligophrenin | pilin | tachykinin | survivin | presenilins | cytophosphane | diindolylmethane{DIM} | estrogen response element {ERE} | near infrared spectroscopy {NIRS} | myosine light chains kinase {MLCK} | myrosinase | quinone reductase {QR} | thioglucoside glucohydrolase | bronchial epithelial cells | clearance | secretion | Food and Drug Administration {FDA} |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
